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Recapitulating Atopic Dermatitis in
Three Dimensions: Cross Talk
between Keratinocytes and Nerve
Fibers
Carlo Pincelli1 and Martin Steinhoff2,3
Roggenkamp et al. (2013) report a significant advance in the in vitro reconstruction
of atopic dermatitis (AD) by coculturing lesional human keratinocytes with
sensory nerve fibers. This work has important implications for understanding
the interaction between the resident skin cells and the peripheral nervous system
in AD, and it sheds light on the pathways leading to the pruritus that typifies this
disease.
Journal of Investigative Dermatology (2013) 133, 1465–1467. doi:10.1038/jid.2013.50
Atopic dermatitis, skin innervation, and
neurogenic inflammation
Atopic dermatitis (AD) is a chronic
inflammatory skin disease characterized
by epidermal barrier disruption, altera-
tions in epidermal homeostasis, and
increased amounts of Th-2-derived cyto-
kines. AD is associated with severe
pruritus, which greatly impairs patients’
quality of life. The skin of patients with
AD is richly innervated, with extensive
sprouting of sensory nerve fibers, sug-
gesting a close correlation between itch
and the peripheral sensory nervous
system. Although intimate contacts
between the sensory nerve and skin
cells have been well described, the
mechanisms linking pruritus to increa-
sed innervation in AD is poorly defined.
Addressing exacerbations of AD in
response to stress, several studies have
demonstrated increased mast cell–nerve
fiber contacts, alterations in the activi-
ties of immune-inflammatory cells, and
the release of neuromediators by sen-
sory nerve endings, leading to neuro-
genic inflammation and pruritus. In
addition, skin cells also produce neural
factors, and thus they can communicate
with adjacent nerves to increase inflam-
matory and pruritic responses (Sua´rez
et al., 2012). This confirms that a
psycho–neuro–immune pathway is—at
least in part—operational in AD,
whereas several therapeutic strategies
are being developed to block this path-
way. However, little is known about the
peripheral involvement of sensory nerve
fibers and their role in AD, in particular
with respect to their interaction with
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resident skin cells, and in the absence
of stimuli from the central nervous
system. The question arises whether
involvement of sensory nerve fibers in
AD is a secondary event following
emotional stress and/or a primary
peripheral pathway that has an important
role in the pathogenesis of the disease.
Cutaneous sensory nerve fibers origi-
nate from the dorsal root ganglia where
the cell bodies of these neurons are
located. Peripheral nerve branches reach
the dermis and move upward into the
epidermis (Zylka et al., 2005). Nerve
growth factor (NGF) and the other
members of the neurotrophin family are
synthesized and released by keratinocytes
and then transported ‘‘antidromically’’ to
the dorsal root ganglia where they
regulate the synthesis and differentiation
of neurons, as well as the production and
release of neuropeptides in the skin,
resulting in neurogenic inflammation
and/or pruritus. For example, calcitonin
gene–related peptide (CGRP), substance
P, or pituitary adenylate cyclase–activa-
ting peptide are expressed differently in
several inflammatory dermatoses, where
they contribute to the ‘‘so-called’’ neuro-
genic inflammation, either by acting
directly on blood vessels or by stimulating
mast cells to release histamine and other
inflammatory mediators (Montan˜o et al.,
2010; Seeliger et al., 2010).
Innervated skin in three-dimensional
in vitro models
Roggenkamp et al. (2013, this issue)
address an important question as to
how sensory nerve fibers and resident
skin cells, with special attention on
keratinocytes, communicate with each
other, as a critical mechanism in the
pathogenesis of AD.
Thus far, our understanding has been
hampered by methodological barriers,
namely the absence of a reproducible
model that would allow investigators to
examine neuronal cells and resident
skin cells of nonrodent origin simulta-
neously. In this issue, the authors used a
novel approach that was based on an
organotypic skin model in which human
keratinocytes and fibroblasts were
cocultured with neurons derived from
porcine dorsal root ganglia. This three-
dimensional skin equivalent was a
major advance from the earlier in vitro
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models, as it was composed of air-
exposed, isolated skin cells, allowing
the investigators to study the biology of
resident skin cells, as well as their
interactions with sensory neurons under
defined conditions. The model definitely
resembles in vivo innervated skin with
the presence of neurites in the dermis
and in close contact with keratinocytes.
Although neurons clearly induce epi-
dermal thickening, through the release
of CGRP, alterations in proliferation
markers in this model should be eval-
uated with caution, given their different
expression patterns in skin equivalents
compared with normal skin, which
sometimes render results difficult to
interpret. Importantly, in some pictures
of Roggenkamp’s work, the epidermal
basal layer is hardly visible. In any
event, blocking experiments with CGRP
and substance P antagonists, along with
the semiquantitative measurements of
epidermal thickness and Ki-67þ cells,
clearly confirm the effects of neuro-
peptide-releasing neurons on epidermal
cells. However, the precise characteris-
tics of the epidermal structure of this
model compared with that of ‘‘real’’
skin are yet to be characterized.
Human skin equivalents generated
from cultured cells have been used
since many years to study epidermal
homeostasis and to test for toxicity of
drugs. More recently, this technology has
been exploited to develop in vitro models
of skin diseases, ranging from inflamma-
tory dermatoses to cancer (Semlin et al.,
2011). Although in vitro skin disease
models picture the pathological situation
at a given point and are yet to be
improved, they certainly will be able to
replace animal models in many respects.
Along this line, Roggenkamp et al.
attempted to reconstruct an in vitro
model of AD by adding keratinocytes
from atopic patients to the innervated
porcine skin equivalent, which, indeed,
resembles the human system more than
the rodent. These investigators had
already succeeded in showing that ato-
pic keratinocytes express higher levels
of NGF, and that they increase neurite
outgrowth compared with healthy kera-
tinocytes (Roggenkamp et al., 2012). In
this issue, these authors refined the
in vitro innervated AD model by show-
ing that atopic keratinocytes express
increased levels of the CGRP receptor
constituent Ramp1, and that elevated
CGRP induces keratinocytes to increase
their proliferation, resulting in epidermal
hyperplasia and acanthosis in association
with reduced expression of filaggrin,
which typify AD lesional skin in vivo.
Taken together, these observations
indicate that the innervated AD in vitro
model partially recapitulates the patho-
physiology of AD in vivo. Whether this
can be extended to address how
immune cells are involved in the
neuro-immune communication between
the resident skin cells and nerve cells is
yet to be determined. The model also
suggests—indirectly—that extensive epi-
dermal fiber density might contribute to
the pruritus of AD. Indeed, excessive
sprouting of nerve fibers that release
elevated amounts of neuropeptides in
AD is accounted for by the increased
Clinical Implications
 Three-dimensional models derived from skin-cultured cells can be
manipulated to reproduce human skin diseases.
 Coculture of keratinocytes from patients with AD and sensory nerve fibers
recapitulates atopic eczema and provides a model to understand pruritus
that is associated with the disease.
 The three-dimensional atopic model can be used to investigate the role of
the peripheral nervous system in the pathogenesis of AD and to test novel
therapies.
Exogenous trigger factors Langerhans cells
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Figure 1. Atopic dermatitis (AD), nerve growth factor (NGF), and nerve fibers. In AD, exogenous
trigger factors (e.g., mechanical stimuli, toxins, proteases, Staphylococcus aureus) can activate
keratinocytes to release NGF and other inflammatory mediators. NGF activates its high-affinity
receptor TrkA on sensory nerve endings in the epidermis and the dermis to mediate NGF-induced
neural activation. Activation of sensory nerve endings results in transmission of a ‘‘pruritic’’ stimulus
to the spinal cord and brain cortex resulting in ‘‘itch sensation’’ and scratching behavior. In addition,
through an antidromal reflex the nerve endings release neuropeptides such as substance P, calcitonin
gene–related peptide, or pituitary adenylate cyclase–activating peptide to mediate neurogenic
inflammation in the skin. Neuromediators can modulate the function of mast cells, T cells, macrophages,
or eosinophils, as well as certain dendritic cells. In a later phase, immune cells and keratinocytes
may also communicate with sensory nerves to aggravate pruritus and the inflammatory condition.
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production of NGF from keratinocytes.
NGF, through its high-affinity receptor
TrkA, seems to have a central role
in pruritus (Indo, 2010). Moreover,
histamine causes increased NGF levels
in human keratinocytes (Kanda and
Watanabe, 2003), and scratching
behavior significantly correlates with
high NGF levels (Yamaoka et al.,
2007). Thus, it may be speculated that
NGF, released in high levels from
keratinocytes in AD patients and
further enhanced by CGRP in an auto-
crine manner, as well as neuropeptide-
induced histamine and trypase release
from mast cells, contribute to pruritus in
AD. On one hand, it can be argued that,
lacking the immunological component,
this model cannot mimic all aspects of
AD. On the other hand, pure immuno-
logical models thus far fail to integrate
the recognized interplay between the
epidermis and the nervous system. In
addition, given the reduced expression
of filaggrin, it is tempting to speculate
that the first trigger in the pathogenesis
of AD could take place in the
dysregulated barrier, thus inducing an
upregulation of NGF in keratinocytes,
followed by the above described
cascade of events eventually leading to
keratinocyte proliferation and epidermal
thickening, accompanied by further
production of NGF giving rise to a
vicious circle. This scenario would
initially take place without primary
intervention of the adaptive immune
system that would subsequently amplify
epidermal and nerve response. Vice
versa, we are in substantial need of
better in vivo models that explain the
complex pathophysiology of how the
adaptive immune system, represented
mainly by the TH2-helper cell and IgE-
producing B cells in AD, or even
dendritic cells, regulate neuro-immune
responses in AD, neurogenic inflamma-
tion, and pruritus, which are definitely a
part of the pathophysiology of AD. Taken
together, in vivo models that integrate the
pathophysiological changes of the
resident skin cells, the adaptive and
innate immune system, and the skin
nervous system are in great demand for
understanding the ‘‘outside-in’’ versus the
‘‘inside-out’’ hypotheses in AD.
In sum, the AD model presented by
Roggenkamp et al. is an important step,
one that can be improved even more to
reproduce the disease pathophysiology
of AD in vivo. In particular, it will be of
great interest to evaluate the model after
blocking the activity of NGF in the
presence or absence of the immuno-
logical component. Finally, the model
described by Roggenkamp et al. could
be exploited to evaluate the efficacy of
the treatment of AD and its related
pruritus, with molecules other than anti-
histamines and immunosuppressants.
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Photosensitivity in the Elderly—Think
of Late-Onset Protoporphyria
Jorge Frank1,2, Pamela Poblete-Gutie´rrez3,4 and Norbert J. Neumann1,2
Photosensitivity is the clinical hallmark of both erythropoietic protoporphyria
(EPP) and X-linked dominant protoporphyria (XLDPP). Both disorders result from
a hereditary dysfunction in heme biosynthesis. Disease onset is usually in early
childhood. However, rare patients with late-onset EPP in association with a
myeloproliferative disorder or myelodysplastic syndrome have been reported. In
this issue, Livideanu et al. describe the first patient with late-onset XLDPP.
Journal of Investigative Dermatology (2013) 133, 1467–1471. doi:10.1038/jid.2013.80
Photosensitivity as the clinical hallmark of
photodermatoses
Photosensitivity comprises any increase
in cutaneous reactivity to sunlight.
Sunlight is composed of B50% visible,
40% infrared, and 10% UV radiation
(Millard and Hawk, 2002). The
biological effects of visible light (electro-
magnetic spectrum 400–800 nm) on the
skin are mostly negligible. However, in
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